Health Archive » February, 2010

Health - February, 2010

203 articles

• Software Co. Edifecs Sues Partner Over Trade Secrets
• Care Centers To Pay $14M In Omnicare Kickback Flap
• Watson Targets Teva's Patent For LoSeasonique
• Judge Won't Nix $22.5M Award In Pfizer Polio Suit
• Congress Urged To Fix Medical Radiation Standards
• J&J Unit Recalls 14,000 Blood Glucose Test Strips
• New MediCor Ch. 11 Plan Factors In Settlements
• Micron Loses Bid To Nix Claims In Drug Contract Spat
• Calif. AG Subpoenas Insurers Over Rate Hikes
• MIT Seeks To Exit Max Planck RNA Patent Suit
• Blue Cross Wins Deductible Class Action In 11th Circ.
• The Financial Case For Law Firm Branding
• KV To Pay $28M Over Ethex Drug Safety Charges
• Novartis Wins Out In Patent Suit Over Hemophilia Drug
• Cordis Wins $4.7M In Fees In MarcTec Stent Patent Suit
• DOJ Charges Guidant In Faulty Defibrillator Case
• Zimmer Loses Appeal To Keep Ex-VP From Rival
• Fed. Circ. Remands Denial Of Antibody Patent
• Active Implants Says Equity Firm Holding It Hostage
• SEC Fraud Claims Against Medical Capital Execs Nixed
• CVS Faces Suit Over Botched IPod Accessories Deal
• Chiropractors Ask To Toss Expert In Claim Fraud Suit
• Pfizer's Bid To Toss Protonix Medicaid Suits Denied
• House Votes To Revoke Insurer Antitrust Exemption
• Another Failed Attempt At Ill. Tort Reform
• SEC Fraud Case Against MedQuist Ex-CFO Trimmed
• Carestream Faces Suit Over Animal Imaging Patents
• GSK Blasts Senate Report On Avandia Risks
• Under Pressure, WellPoint Execs Stand By Rate Hikes
• Warner-Lambert Retirees Hit Pfizer Over Health Plan
• Synthes Bone Plate Patent Suit Stayed For Re-Exam
• Pfizer Seeks Sanctions In Wyeth Deal Antitrust Suit
• Mexico Fines Lilly, Others $12M For Price Collusion
• US Widens Probe Into Eli Lilly's FCPA Compliance
• Mont., Lilly Reach $9.5M Deal In Zyprexa MDL
• Novartis, Bayer Settle IP Spat Over Hemophilia Drugs
• KV Pharma Shareholder Suit Over Recalls Nixed
• Neurontin Suicide Case Survives Pfizer's Bid To Toss
• AndroGel Reverse Payment Suits Thrown Out
• Obama Takes Aim At Insurance Antitrust Exemption
• Pfizer Must Pay $9.5M In Another Prempro Verdict
• Allegra Suits Dropped After Sandoz Amends ANDAs
• Actavis Failure-To-Warn Suit Not Preempted: Judge
• 7th Circ. Rules Paxil Suicide Case Not Preempted
• AntiCancer Defends Validity Of Cancer Imaging Patents
• FDA Calls GSK's Avandia Safe Amid Public Concerns
• Triton Nabs Swedish Health Care Co. Ambea For $1.2B
• Rule 56 Compliance And The PTA Shield Of Rule 704
• OFT Accuses Reckitt Of Limiting Generic Access
• 3M Slaps Safe Life With Patent Suit Over Respirators
• Hedge Fund Hits Back At Biovail's 'False' Fraud Suits
• Digitek Defendants Seek to Block Class Cert.
• Sandoz Unit To Pay $3.5M In False Claims Act Deal
• Amicas Rejects $248M Rival Offer From Merge
• Tyco, Applied Medical Patent Battle To Move Ahead
• High Court Seeks SG Input On Procrit Whisteblower Suit
• McKesson, Angeles Ink $4.5M Deal To End Enviro Feud
• Senators Slam GSK, FDA On Avandia Safety
• Plaintiffs Fight Privilege Claim In Neurontin Case
• New Fees, Oversight In White House Health Care Bill
• Biovail Hammers Watson Over Aplenzin ANDA
• CORRECTED: Part Of Crestor Case Moves To Fla.
• FTC Has Shot At Victory In Pay-For-Delay Suits: Attys
• Hologic, J&J Unit Strike $12.5M Deal In Biopsy IP War
• Liberty Mutual, Aetna Put $20M E&O Fight On Hold
• Columbia's Patent Extension Spat To Return To USPTO
• Fraud Suit Against Walgreens Dismissed Again
• Waxman Calls Out WellPoint On Rate Hike Explanation
• Bayer Sues Lupin Over Generic Cipro
• Consumer Claims Pared In Redline Advertising Action
• 2nd Class Cert. Bid In Nurse Antitrust Suit Denied
• Asthma Drugs Get New Rules After FDA Finds Death Link
• Patton Boggs Lands Top Bristol-Myers Squibb Exec
• Teva Appeals Win For Pfizer In Detrol Patent Suit
• Novartis' Maalox Labels Linked With Serious Errors
• Patent Dispute Freezes Cold Sore Treatment Case
• Increasing Quality With Six Sigma
• GSK Recalls Zinc Denture Cream Products Amid MDL
• J&J Can't Revive Claims Against Abbott, Boston Sci
• Lupin Aims To Invalidate Ortho Birth Control Patent
• HHS Scolds Health Insurers For Requested Rate Hikes
• ReNu Lens Solution MDL Slashed By 100s Of Suits
• J&J Appeals Invalidity Ruling For Stent Patents
• Ill. Medical Imaging Center Antitrust Suit Tossed
• Grassley Demands Details On FDA 510(k) Update
• Roche Hit With $25M Accutane Verdict
• Plaintiff Class Wants Bristol-Myers AWP Deal Enforced
• USPTO Faces Another Suit To Extend Drug Patent
• 3rd Circ. Says Rite Aid Union Dispute Not Arbitrable
• Smith & Nephew Wins $4.7M In Arthrex Patent Spat
• Clinical Investigators Beware: Greater FDA Review
• ERISA, RICO Claims Out In Pittsburgh Hospital Pay Suit
• Walgreen To Snap Up Duane Reade For $1.1B
• Senate Dems Revive Push For Public Option
• Horny Goat Weed Deflates Pfizer's Viagra Patent
• Pfizer Experts Escape Judge's Boot In Neurontin Case
• Abbott Sues Sun Pharma Again Over Generic Niaspan
• J&J Unit Escapes Artificial Disc Negligence Claims
• Watson Settles Mass. Medicaid Fraud Suit For $2.4M
• Lilly Settles Ark.'s Zyprexa Marketing Suit For $18.5M
• Bayer Asks To Stop Nazi References In Trasylol MDL
• State Farm Payouts Violate Fla. No-Fault Law: Court
• Predicting SCOTUS In Merck V. Reynolds
• Teva, Novartis Settle Suit Over Generic Famvir
• Monsanto, Others Sued Over DNA Patent
• Prosthetic Liner Antitrust Claims Have Legs: Judge
• Indian Court Won't Block Generic Nexavar
• Pegasus, Allscripts Software IP Spat Headed To Jury
• Fund's Trasylol Marketing Suit Against Bayer Nixed
• WellPoint Defends Calif. Health Insurance Rate Hikes
• Lender Fights TLC Vision's Charlesbank Deal
• Judge Tosses Antitrust Claim In Ciba Vision IP Suit
• Pharmacies Stung In Medicaid Rates Suit V. Minn.
• Ariad: Sea Change Or Tempest In A Teapot?
• Couple Fined $4M In Biotech Insider Trading Scheme
• Perrigo ANDA Doesn't Infringe Mucinex Patent: Judge
• Judge Paves Way For McKesson To Appeal IP Loss
• Pretrial Clashes Intensify In Neurontin Off-Label MDL
• 9th Circ. Remands Neuralstem Stem Cell IP Suit
• Judge Nixes CVS 'Tactical Manipulation' In OT Suit
• Judge Tosses 'Borrowed' Suit Over Bayer Vitamins
• Abbott Divestment Wins EU OK For $6.6B Solvay Deal
• Digitek Plaintiffs Win Bid For Actavis Audit Docs
• United Insurers Dodge $400M In Settlement Claims
• Jury To Hear Max Planck RNA Interference Patent Suit
• Kasowitz Benson Hits Up Duane Reade For $7M Fee
• Curbing Antitrust Liability For New Products
• Dentsply Wants $44M Contract Suit Verdict Overturned
• Citigroup, KV Wrap Up ARS MDL Case
• Hogan & Hartson Wants To See Sealed Medtech Deal
• Sony Acquires Stem Cell Research Co. ICyt
• $12M Vioxx Deal Requires Merck To Add Safety Checks
• Acacia Recalls 217K IV Devices Over Faulty Component
• House Panel To Probe Anthem Blue Cross Rate Hike
• Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.
• CCS Medical Disclosure Statement Approved
• Alza, Sandoz Pain Patch Case Stays In Federal Court
• Injunctions In District Courts And The ITC
• Drug Cos. Raise NY Law Query After AWP Loss
• Plaintiffs Ask Court To Revisit Neurontin Ruling
• Obamas Launch Fight Against Childhood Obesity
• UK Court Affirms Invalidity Of Gene Patent In Lilly Suit
• Howrey To Remain As BSC Counsel In Stent IP Suit
• Dykema's Rates Help Land Ex-Greenberg Litigator
• FDA Seeks To Reduce Radiation In Medical Scans
• Insurers Can't Dodge Cancer Patient Payout: 4th Circ.
• Texas A&M Blocked From Using Dog DNA Test Patents
• Coloplast Sues Generics Co. Over Incontinence Patents
• Officials Sound Alarm On Anthem Blue Cross Rate Hike
• Fat Removal Cos. Strike Licensing Deal In Patent Suit
• Class Cert. Denied In Health Temp Agency FLSA Suit
• Case Study: Donovan V. Philip Morris
• Becton Pulls Potentially Lethal IV Catheters
• Ortho Evra Plaintiffs Challenge Limited MD Contact
• Idera Sues USPTO To Extend Cancer Treatment Patents
• Judge Narrows Arguments In Arthrex Patent Trial
• DLA Piper Picks Up King & Spalding Litigator
• Granting A New Trial In Texas?
• Off-Label Marketing Ripe For Enforcement In 2010
• Fed. Circ. Nixes Pfizer Bid To Keep Lipitor IP Suit In Del.
• Reps To Pose Insurance Antitrust Exemption Repeal
• Physicians Group, FTC Settle Price-Fixing Suit
• Last Class Claims Tossed In ReNu Infection MDL
• Teva To Pay $315M To Settle Price Inflation Suits
• Reinsurer Gen Re Life Hits Insurer With False Ad Suit
• TLC Vision Eyes New Plan With Private Equity Backing
• SD Legislature Says No To Federal Health Care Bills
• Freedom Drops Market-Cornering Claims V. Novation
• Cardiac Science Recalls 12,200 Faulty Defibrillators
• Medtronic Securities Action Survives Dismissal Bid
• Bristol-Myers Worker Charged With Trade Secrets Theft
• Lilly To Pay Miss. $18.5M Over Zyprexa Marketing
• Inverness To Pay $110M For Kroll Drug Testing Unit
• McCain Proposal Would Increase Supplement Oversight
• Spheris Files Ch. 11 To Sell Off Assets For $75M
• GSK Sales Reps Appeal Dismissal Of OT Action
• Expert Testimony Back In Play In Accutane Death Suit
• A Response To 'NuvaRing Meets Iqbal'
• Pfizer Sues Mylan To Block Generic Caduet
• AtriCure Settles Medicare Fraud Claims For $3.8M
• FDA Says Eli Lilly Overstates Benefits Of Adcirca
• Agencies Roll Out Rules On Mental Health Coverage
• 2nd Circ. Shoots Down Zyprexa MDL Atty's Fee Appeal
• Jones Day Makes 3 More Lateral Hires In Calif.
• 3rd Circ. Tosses False Claims Suit Against Organon
• A Brief Overview Of MMSEA
• Medicis Sues Lupin To Halt Generic Acne Drug
• Nipro To Snap Up Home Diagnostics For $215M
• EU OKs $5B Deal Joining IMS Health, Investment Funds
• Lancet Retracts Study Linking MMR Vaccine To Autism
• 3rd Circ. Shoots Down J&J Sales Reps' OT Action
• Myriad, ACLU Square Off At Gene Patent Hearings
• Hologic Seeks 2nd Look At Ethicon Willfulness Claim
• Celgene, Novartis Settle With Teva In Focalin IP Suits
• Merge Wants Ex-Execs To Pay Back Defense Fees
• Applikon Fights Customs Over Bioreactor Duties
• Boston Scientific To Pay J&J $1.7B In Stent Settlement
• La. AG Wants Vioxx Suit Returned To State Court
• Robot Not Cause Of Patient's Impotence: 3rd Circ.
• Baylor Loses Bid To Force Insurer To Arbitrate Contract
• USPTO, FDA Sued Over Angiomax Patent Extension
• Affirming The Right To Rescind In Calif.
• Cephalon To Buy Swiss Drugmaker Mepha For $590M